Skip to main content
CTOS 2023 Main banner
Final Program


Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Paper 78 - A NOVEL SURGICAL COMPLEXITY SCORE TO PREDICT POSTOPERATIVE MORBIDITY FOR PRIMARY RETROPERITONEAL SARCOMA: THE FIRST TARPSWG STUDY FROM THE PROSPECTIVE RESAR REPOSITORY

Saturday, November 4, 2023
2:00 PM – 3:00 PM  

    Author(s)

  • Mark Fairweather, MD

    Surgical Oncologist
    Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston
    Boston, Massachusetts, United States

    Slides

    • Co-Author(s)

  • Jolissaint S. Joshua, MD, MSc

    Fellow
    Department of Surgery, Memorial Sloan Kettering, Cancer Center
    New York, New York, United States

  • Marco Fiore, MD, FEBS, FACS

    Attending Surgical Oncologist
    Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Milano, Lombardia, Italy

  • Dirk Strauss, MD

    Surgical Oncologist
    Royal Marsden NHS Foundation Trust
    London, England, United Kingdom

  • Sylvie Bonvalot, MD, PhD

    Head, Sarcoma surgery
    Institut Curie
    Paris, Ile-de-France, France

  • SF

    Samuel Ford, MD, PhD

    Department of Surgery, University Hospitals Birmingham
    Birmingham, England, United Kingdom

  • Winan J. van Houdt, MD, PhD, MS

    Surgical Oncology
    Netherlands Cancer Institute/ Antoni van Leeuwenhoek
    Amsterdam, Noord-Holland, Netherlands

  • CS

    Carol Swallow, MD, PhD

    Mount Sinai Hospital, Toronto, ON, Canada
    Toronto, Ontario, Canada

  • Piotr Rutkowski, MD, PhD

    Head of Department of Soft Tissue/Bone Sarcoma and Melanoma
    Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Department of Soft Tissue/Bone Sarcoma and Melanoma
    Warsaw, Mazowieckie, Poland

  • David E Gyorki, MD (he/him/his)

    Surgical Oncologist
    Peter MacCallum Cancer Centre
    Melbourne, Victoria, Australia

  • MF

    Migalie Fau, MD

    Department of Surgery, Institut Bergonie
    Bourdeaux, Rhone-Alpes, France

  • John Mullinax, MD

    Associate Member
    Moffitt Cancer Center
    Tampa, Florida, United States

  • Markus Albertsmeier, MD

    Consultant
    Department of General, Visceral and Transplantation Surgery, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Germany
    Munich, Bayern, Germany

  • Carolyn Nessim, MD (she/her/hers)

    Surgical Oncologist, Associate Professor, Clinician Investigator
    Department of Surgery, University of Ottawa
    Ottawa, Ontario, Canada

  • Vittorio Lorenzo Quagliuolo, MD

    Senior Consultant Sarcoma and Melanoma Unit
    IRCCS Humanitas Research Hospital
    Rozzano, Milan, Lombardia, Italy

  • Valerie P. Grignol, MD

    Associate Professor of Surgery
    The James Cancer Hospital / The Ohio State University
    Columbus, Ohio, United States

  • Kenneth Cardona, MD

    Associate Chief Medical Officer, Winship Cancer Institute of Emory
    Department of Surgery, Winship Cancer Institute, Emory University
    Atlanta, Georgia, United States

  • JG

    José Antonio Gonzalez, MD, PhD

    Department of Surgery, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Barcelona, Catalonia, Spain

  • Elisabetta Pennacchioli, MD

    Director
    Division of Melanoma, Sarcoma, and Rare Tumor Surgery, European Institute of Oncology
    Milan, Lombardia, Italy

  • Marko Novak, MD

    Surgical Oncologist
    Department of Surgery, Institute of Oncology Ljubljana
    Ljubljana, Ljubljana, Slovenia

  • MR

    Marco Rastrelli, MD

    Department of Surgery, Veneto Institute of Oncology IOV-IRCCS
    Padua, Veneto, Italy

  • Sergio Valeri, MD

    Surgical Oncologist Chair Surgical Sarcoma Service – Department of Surgery
    Sarcoma Surgery, Fondazione Policlinico Universitario Campus Bio-Medico
    Rome, Lazio, Italy

  • MW

    Michelle Wilkinson, MD PhD

    Sarcoma Unit, Department of Surgery, Royal Marsden Hospital, Royal Marsden NHS Foundation Trust
    London, England, United Kingdom

  • Dimitri Tzanis, MD, PhD (he/him/his)

    Consultant Surgical Oncologist
    Institut Curie
    Paris, Ile-de-France, France

  • Yvonne Schrage, MD, PhD

    Surgical Oncologist
    Netherlands Cancer Institute/ Antoni van Leeuwenhoek
    Amsterdam, Noord-Holland, Netherlands

  • Rebecca Gladdy, MD, PhD (she/her/hers)

    Surgical Oncologist Clinician-Scientist Associate Professor of Surgery
    Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON
    Toronto, Ontario, Canada

  • JS

    Jacek Skoczylas, MD

    Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology
    Warsaw, Opolskie, Poland

  • Alessandro Gronchi, MD, FSSO (he/him/his)

    Chief Sarcoma Service and Chair of the Department of Surgery
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Milan, Lombardia, Italy

  • Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his)

    Surgical Oncologist
    Brigham and Women’s Hospital/Harvard Medical School
    Boston, Massachusetts, United States